Back to Trades
Grant4
MADRIGAL PHARMACEUTICALS, INC.
MDGL
Total Value
$2.4M
Company Information
- Company Name
- MADRIGAL PHARMACEUTICALS, INC.
- Ticker Symbol
- MDGL
- CIK
- 0001157601
Insider Information
- Name
- Soergel David
- Role
- Chief Medical Officer
- Location
- WEST CONSHOHOCKEN, PA
Officer
Filing Details
- Filing Date
- Mar 6, 2026
- Transaction Date
- Mar 4, 2026
- Accession Number
- 0001628280-26-015722
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | 4,374 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Derivative | 5,467 | $434.80 | Grant/Award | $2.4M |
Footnotes
- (F1)Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
- (F2)The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.